Methotrexate significantly lowers systolic blood pressure in newly diagnosed RA patients compared to sulfasalazine, potentially reducing cardiovascular risk. The study provides prospective comparative ...
Background: We set out in this study to demonstrate the adverse effect profile of methotrexate when used in the treatment of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) in a district ...
Methotrexate is the gold standard of care for RA, but it can also disrupt a pregnancy. In states with strict anti-abortion laws, some women with RA cannot get their routine medication easily or ...
Please provide your email address to receive an email when new articles are posted on . Patients with RA treated with first-line upadacitinib over 5 years had greater reductions in disease activity vs ...
Please provide your email address to receive an email when new articles are posted on . Upadacitinib monotherapy, at 15 or 30 mg daily, significantly improves clinical, radiographic and ...
Health and Me on MSN
Taking methotrexate for arthritis? Doctors explain the risks behind the latest warning
Methotrexate is widely prescribed for arthritis, psoriasis, and certain cancers. Here’s what patients need to know about ...
The chronic nature of rheumatoid arthritis (RA) means that patients require drug therapy for many years. Many RA patients, however, have to discontinue treatment because of drug-related toxic effects, ...
Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognised useful secondary effect to lower blood pressure and potentially reduces the risk of heart disease in people ...
Leflunomide and methotrexate are prescription drugs used to treat rheumatoid arthritis (RA). Methotrexate is also used to treat certain other conditions, including psoriasis. This article explains the ...
Methotrexate is a prescription medication. It comes in four forms: self-injectable solution, injectable IV solution, oral tablet, and oral solution. For the self-injectable solution, you can receive ...
Greater risks of toxic effects were found at higher methotrexate doses and lower eGFR. Older patients with chronic kidney disease (CKD) starting low-dose methotrexate rather than hydroxychloroquine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results